Newsig · Financial Times
Ozempic-maker Novo open to upgrading US listing
Boss Mike Doustdar says he sees ‘advantages’ in giving US investors direct access to Danish group’s stock
Why it matters
XLV (Health Care Select Sector) · Why linked: Novo Nordisk is a major global healthcare name with outsized weight in healthcare benchmarks. Market context: Improved US access for a heavyweight pharma name can be a modest tailwind for the healthcare sector ETF.
Reaction tracking
A completed 24-hour reaction record is not available for this story yet. Newsig only publishes measured price movement when the required market data is present.
Curated by Newsig — News in. Signal out.
How the reaction data is measured · Editorial policy